Autopsy report · NCT02186405

Effects of Levothyroxine Treatment on Hemodynamic and Renal Functions in Subclinical Hypothyroidism

“No patient corresponding to inclusion criteria couldn't be enrolled in the study”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

Centre Hospitalier Universitaire de Nice

Sponsor type

University, hospital or other

Conditions

Subclinical hypothyroïdism

Interventions

LEVOTHYROXINE

Participants

0

Sites

1

Countries

France

Trials that died the same way

• Bioavailability of Voriconazole
  “no eligible patients; study stopped without inclusion” (88% match in meaning)
• Sirolimus for the Treatment of Hyperinsulinism
  “Due to strict inclusion and exclusion criteria no subjects were enrolled” (77% match in meaning)
• Study of Viscosupplementation for the Treatment of Knee Pain After Menisectomy
  “Patients did not meet inclusion criteria.” (76% match in meaning)
• Hepatitis C in Prison: Study of Screening and Rapid Treatment (HEPAPRIS)
  “No patient eligible” (76% match in meaning)
• Pharmacokinetic Study of Recombinant AT III in Neonates Undergoing ECMO
  “Unable to enroll patients into study.” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.